#drug development — Wednesday, April 01, 2026 (2 items)
| 0 | ℹ |
Iotadentification of SQ109 analogs with enhanced antimicrobial activity against methicillin-resistant Staphylococcus aureus.
(journals.asm.org)
|
Antimicrobial Agents and Chemotherapy 2026-04-01 | #amr #membrane #drug development | |
| 0 | ℹ |
Zodasiran for cholesterol and triglyceride lowering in patients with hyperlipidemia: final report of phase 1 basket trial.
(nature.com)
|
Nature Medicine 2026-04-01 | #metabolism #rnai #drug development #hyperlipidemia |